Neuroinflammatory diseases and the importance of a healthy blood-brain barrier

Current Opinion in Investigational Drugs

Volumn 9, Issue 11, 2008, Pages 1149-1150

  Elices, M J ^a  

^a PharmaMar USA Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; CLAUDIN; FINGOLIMOD; FLUINDOSTATIN; GLUCOCORTICOID; OCCLUDIN; PROTEIN KINASE C DELTA; PROTEIN ZO1; PROTEIN ZO2; PROTEIN ZO3; THIOCTIC ACID; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; BRAIN TUMOR; DEMYELINATION; DRUG TARGETING; EDITORIAL; HUMAN; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; OBESITY; PROTEIN FUNCTION; STROKE; TIGHT JUNCTION;

ANIMALS; BLOOD-BRAIN BARRIER; HUMANS; MULTIPLE SCLEROSIS;

EID: 54949156102     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (15)

1. Hirschi KK, D'Amore PA: Pericytes in the microvasculature. Cardiovasc Res (1996) 32(4):687-698.
2. Wosik K, Cayrol R, Dodelet-Devillers A, Berthelet F, Bernard M, Moumdjian R, Bouthillier A, Reudelhuber TL, Prat A: Angiotensin II controls occludin function and is required for blood-brain barrier maintenance: Relevance to multiple sclerosis. J Neurosci (2007) 27(34):9032-9042.
3. Krause G, Winkler L, Mueller SL, Haseloff RF, Piontek J, Blasiq IE: Structure and function of claudins. Biochim Biophys Acta (2008) 1778(3):631-645.
4. Chou W-H, Messing RO: Hypertensive encephalopathy and the blood-brain barrier: Is δPKC a gatekeeper? J Clin Invest (2008) 118(1):17-20.
5. Fanning AS, Little BP, Rahner C, Utepbergenov D, Walther Z, Anderson JM: The unique-5 and -6 motifs of ZO-1 regulate tight junction strand localization and scaffolding properties. Mol Biol Cell (2007) 18(3):721-731.
6. Frohman EM, Racke MK, Raine CS: Multiple sclerosis - the plaque and its pathogenesis. N Engl J Med (2006) 354(9):942-955.
7. Trapp BD, Nave KA: Multiple sclerosis: An immune or neurodegenerative disorder? Annu Rev Neurosci (2008) 31:247-269.
8. Banks WA: The blood-brain barrier as a cause of obesity. Curr Pharm Des (2008) 14(16):1606-1614.
9. Schreibelt G, Musters RJP, Reijerkerk A, de Groot LR, van der Pol SM, Hendrikx EM, Dopp ED, Dijkstra CD, Drukarch B, de Vries HE: Lipoic acid affects cellular migration into the central nervous system and stabilizes blood-brain barrier integrity. J Immunol (2006) 177(4):2630- 2637.
10. Qi X, Inagaki K, Sobel RA, Mochly-Rosen D: Sustained pharmacological inhibition of δPKC protects against hypertensive encephalopathy through prevention of blood-brain barrier breakdown in rats. J Clin Invest (2008) 118(1):173-182.
11. Lee MR, Duan W, Tan SL: Protein kinase C isozymes as potential therapeutic targets in immune disorders. Expert Opin Ther Targets (2008) 12(5):535-552.
12. Algotsson A, Winblad B: The integrity of the blood-brain barrier in Alzheimer's disease. Acta Neurol Scand (2007) 115(6):403-408.
13. Wyss-Coray T: Inflammation in Alzheimer disease: Driving force, bystander or beneficial response? Nat Med (2006) 12(9):1005- 1015.
14. Arnaud L, Robakis NK, Figueiredo-Pereira ME: It may take inflammation, phosphorylation and ubiquitination to 'tangle' in Alzheimer's disease. Neurodegener Dis (2006) 3(6):313-319.
15. Romanitan MO, Popescu BO, Winblad B, Bajenaru OA, Bogdanovic N: Occludin is overexpressed in Alzheimer's disease and vascular dementia. J Cell Mol Med (2007) 11(3):569-579.